文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 自然科学 > 生物学 > Persistent DNA damage caused by low levels of mitomycin C induces irreversible cell senescence
侵权投诉

Persistent DNA damage caused by low levels of mitomycin C induces irreversible cell senescence

DNA damage, Mitomycin, cell senescence

Persistent DNA damage caused by low levels of mitomycin C induces irreversible cell senescence

approach are considered to rely on targeting vascular endothe-lial cells in the tumor bed that support tumor growth.15 Indeed, two in vivo animal studies that preceded the clinical adoption of metronomic chemotherapy, one using cyclophosphamide to treat Lewis lung carcinoma29 and the other using vinblastine to treat neuroblastoma,30 demonstrated that more frequent administra-tion of drug increased apoptosis in endothelial cells, followed by apoptosis in tumor cells. The possible induction of senescence in tumor cells, however, was not carefully monitored. Due to the fact that senescence is seen as part of the response to high-dose cytotoxic chemotherapy and in light of the results of this study, it is likely that senescence of tumor cells during metronomic che-motherapy also plays significant role.

Cell senescence is induced by a combination of both inhibi-tion of cell cycle progression and the ongoing activity or activa-tion of mTOR pathways.31-34 In the absence of mTOR activation, inhibition of cell cycle progression is, in and of itself, not suf-ficient to generate cellular senescence.33 On the other hand, enhancement of senescence can be achieved by overexpression of the oncogenic pathways that promote downstream activa-tion of mTOR, increase S6 ribosomal protein signaling and enhance translation activity.35-37 Many tumor suppressors exert inhibitory activity on these translation-activation pathways and, when mutated, lose this capability, which also leads to mTOR/S6 activation. Nearly all cancers have either dysfunctional onco-genes or tumor suppressor genes, or both. Therefore, by having constitutively activated mTOR and S6 ribosomal protein signal-ing, cancer cells are expected to be more predisposed to undergo senescence under conditions of persistent replication stress than normal cells. Assessment of the dysfunctional oncogenes and/or tumor suppressor genes that activate mTOR and/or 6S ribosomal protein pathways may be performed prior to therapy providing information about the potential propensity of the particular can-cer to undergo senescence. Screening tumors for the presence of activation of such oncogenes may select the patients as potentially sensitive for the metronomic type of chemotherapy, offering an approach for personalized cancer treatment. In addition to a large number of “Achilles’ heels” of cancer that potentially sensitize it to the particular treatment,38,39 the mutation of oncogenes that leads to enhanced mTOR signaling may provide still another of such “heels” that may be of clinical utility.

It should be noted that the A549 cells used in the present study have several oncogenic changes, such as in K-Ras which is mutated at Gly,12 the oncogenic microRNA let-7a-3 and TAZ (transcriptional coactivator with PDZ-binding motif).40-42 These mutations also appear to be common to human non-small cell lung carcinoma.43 It has also been observed that A549 cells are quite susceptible to undergoing senescence when treated with bone morphogenetic protein BMP4, which is one of the sub-groups of the transforming growth factor-β (TGF-β) protein superfamily.44 Therefore, it is possible that this type of cancer, which is the most common of the lung cancer types, may be par-ticularly sensitive to therapy that is designed to induce senescence in tumor cells.

Metronomic chemotherapy has been shown to have clinical benefits with relatively low toxicity to patients, though there is

Figure 3. Induction of γH2AX in cells treated with MMC. exponentially growing, A549 cells were untreated (control) or exposed to 0.01 or 0.02 μg/ml MMC for 3 or 6 d. (A) Bivariate distributions reveal expres-sion of γH2AX as a function of DNA content. (B) Mean γH2AX expression for the total cell populations shown as n-fold increase above γH2AX mean of the untreated cells.

little consistency among the various treatment regimens and only superficial understanding of its underlying principle(s).The pres-ent findings indicate that DNA damaging agents if given at a low dose (1/100 of the MTD) continuously (or at least frequently) can induce irreversible senescence in the entire tumor cell popu-lation. These findings therefore, call for further testing of this approach on animal tumor models with particular attention paid to induction of senescence in the tumor cell population. Positive data from animal tests may promote application of this low-dose, long-term chemotherapy approach in clinical trials in anticipa-tion of clinical benefits with considerably fewer attendant side effects.

Materials and Methods

Cells, cell treatment. Human pulmonary carcinoma A549 cells were obtained from American Type Culture Collection. The cells were grown in 25 ml FALCON flasks (Becton Dickinson Co.) in Ham’s F12K media supplemented with 2 mM L-glutamine,10% fetal bovine serum, 100 units/ml penicillin and 100 μg/ml strep-tomycin (all from Invitrogen/GIBCO) at 37°C in an atmosphere of 5% CO2 in air. The cultures were re-plated every 4 d to main-tain cells in an asynchronous and exponential phase of growth. For experiments, the cells were trypsinized and seeded at low cell

3136 Cell Cycle Volume 11 Issue 16

上一页第5页

TOP相关主题

你可能喜欢

热门文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email